The American Academy of Pain Medicine announced today that its Immediate Past President Sean Mackey, MD, PhD and former Board Member and leader of the Academy, Chester “Trip” Buckenmaier III, MD, COL (ret), USA, were awarded the highly prestigious National Institutes of Health Director’s Award.
The AAPM joins the Obama Administration’s efforts to address the growing crisis of opioid abuse.
AMA Task Force to Reduce Opioid Abuse comprised of 27 physician organizations including the American Academy of Pain Medicine.
American Academy of Pain Medicine (AAPM) will return to the PAINWeek conference for the third consecutive year to contribute its expertise in pain management to the agenda.
The American Academy of Pain Medicine (AAPM) applauds the release of the draft National Pain Strategy (NPS) for public review. Long overdue, the report addresses key target areas including: public awareness and clinical education, access to better care, research into new treatment options, and gathering data on the prevention and treatment of pain.
Intravenous (IV) cosyntropin therapy was equivalent to epidural blood patch (EBP) in relieving pain from post-dural puncture headache (PDPH) with potential for fewer complications and lower costs, data from a randomized, controlled trial showed.
A sympathetic nerve block that has shown promise for treatment of post-traumatic stress disorder (PTSD) performed no better than sham treatment in a randomized controlled trial, new research shows.
Early gains in pain relief, behavioral markers and function were not sustained in patients treated with platelet-rich plasma (PRP) injection for facet joint arthropathy, new research shows.
The first-ever randomized, controlled trial to compare spinal cord stimulation (SCS) technologies found that high-frequency SCS using 10 kHz (HF10) exceeded lower-frequency, traditional SCS in response rate and pain relief
The main driver of patient experience depends less on the individual provider than on the overall coordination among the clinic, the primary care physician and all others who participate in delivery of care, Stanford researchers reported.
Markovian models show promise for describing postoperative pain states and, eventually, may help guide clinical decisions, a new study found.
Mesenchymal stem cell (MSC) transplantation reduced opioid tolerance and opioid-induced hyperalgesia caused by daily morphine injections in rats, according to new research.
American Academy of Pain Medicine Announces 2015 Pain Medicine Fellowship Excellence Awards
The American Academy of Pain Medicine (AAPM) is pleased to announce its 2015 Presidential Commendations for exceptional service to the Academy and/or the field of Pain Medicine. Recipients will be honored on Saturday, March 21, 2015 at AAPM’s Annual Meeting in National Harbor, MD, where more than 1,000 scientists, physicians and key nonphysician providers convene to discuss and learn the latest in Pain Medicine.
The American Academy of Pain Medicine (AAPM) is pleased to announce its Pain Medicine 2015 Awards for exceptional service to the Academy and/or the field of Pain Medicine. Recipients will be honored on Saturday, March 21, 2015 at AAPM’s Annual Meeting in National Harbor, MD, where more than 1,000 scientists, physicians and key nonphysician providers convene to discuss and learn the latest in Pain Medicine.
American Academy of Pain Medicine Welcomes New President, Bill McCarberg, MD
The American Academy of Pain Medicine (AAPM) is pleased to announce Tim J. Lamer, MD as AAPM’s Secretary. Dr. Lamer assumes his new position on Saturday, March 21, 2015 at AAPM’s Annual Meeting in National Harbor, MD, where more than 1,000 scientists, physicians and key nonphysician providers convene to discuss and learn the latest in Pain Medicine.
American Academy of Pain Medicine Welcomes New President-Elect, Daniel B. Carr, MD
The American Academy of Pain Medicine's Annual Meeting Keynote Address will focus on the National Pain Strategy Task Force.
AAPM is offering a full day of free education at its Annual Meeting that includes a neuromodulation course, two commercially-supported symposia, and entrance to the meeting's Welcome Reception.
AAPM's Annual Meeting runs March 19-22, 2015 at Gaylord National Resort & Convention Center in National Harbor, MD, with preconference sessions beginning on Wednesday, March 18, 2015. Those interested in attending or learning more about the event should visit www.painmed.org/annualmeeting.
Not only are neuropathic pain symptoms quite common in knee osteoarthritis (OA), but scientists can predict who will respond to treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) by assessing the nervous system’s own capacity to regulate pain, new research suggests. Patients whose tests had indicated superior conditioned pain modulation (CPM) had less pain and fewer neuropathic symptoms at study’s end, in results reported in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine.
Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans. Recent developments in stem cell research have made it possible to assess its effect on intervertebral disc (IVD) height, Mayo Clinic researchers reported in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine.
Two hormones credited with reducing pain and need for opioid analgesics when released naturally during pregnancy and childbirth worked similarly when administered simultaneously to patients with intractable pain, research shows.
A multidisciplinary treatment plan that combined splint use, physical therapy and discontinuation of bisphosphonates brought excellent results for a 58-year-old woman diagnosed with bisphosphonate-related osteonecrosis of the jaw (BRONJ). The treatment team and study authors highlighted the effectiveness of advanced imaging technology and multidisciplinary collaboration for patient outcomes that included a 90% decrease in pain, improved function and normalized imaging results. They presented study results today in a scientific poster at the 30th Annual Meeting of the American Academy of pain Medicine.
As more people in the United States become severely obese, bariatric surgery has grown in popularity as a corrective measure; however, serious neurologic complications can result immediately after surgery or even years later (Juhasz-Pocsine et al, Neurology 2007;68(21):1843-50).
Not only are neuropathic pain symptoms quite common in knee osteoarthritis (OA), but scientists can predict who will respond to treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) by assessing the nervous system’s own capacity to regulate pain, new research suggests. Patients whose tests had indicated superior conditioned pain modulation (CPM) had less pain and fewer neuropathic symptoms at study’s end, in results reported in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine.
Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30th Annual Meeting of the American Academy of Pain Medicine reported on a number of factors associated with opioid discontinuation with the goal of understanding how abuse problems take hold in returning veterans.
Prescriptions for benzodiazepines are rising in primary care, and their frequent combined use with opioid analgesics may be contributing to medication-related deaths, a finding that goes largely unreported, according to Stanford researchers.
Postsurgical pain scores were highly correlated with reports of overall patient satisfaction during hospital stays, in a new finding that was true for some types of surgery more than others. The researchers, who presented results in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine, stressed the importance of improving patient care in the peri-operative setting in alignment with new federal requirements tying performance to pay.
The spread of close to 80% of injectate to surrounding soft tissues following a nerve block to treat chronic pelvic pain suggests a need to reduce the quantity injected, according to study authors, who presented results in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine.
Determining MRI RF heating safety is a complex process that requires complete understanding of the potential interactions between the MRI system, lead behavior, and individual patient characteristics.1 A comprehensive analysis was performed to evaluate a new MR-compatible SCS lead. Materials and Methods: Anesthetized porcine (Sus scroffa; n = 5) were implanted with leads and temperature probes in the spinal canal (Figure 1) and scanned in a 1.5T MRI system at multiple landmarks. MRI RF heating predictions from animal model simulations were compared to in vivo electrode temperature measurement to confirm model accuracy. Multiple human models were combined with several MRI coils to simulate the electromagnetic effects due to variations in human morphology. Simulations were performed for hundreds of clinical lead paths in each human model and combined with lead characterization analyses to predict the temperature rise at the electrodes in the spinal cord for each patient situation.
Two commonly delivered epidural injection modalities deliver minimal differences in pain relief and function at 1 and 6 months, new research shows. Results presented today at the 30th Annual Meeting of the American Academy of Pain Medicine indicate both injection types were effective for treating unilateral lumbosacral radicular pain (ULSRP).
Patients who benefited from intradiscal biacuplasty (IDB) to treat discogenic low-back pain maintained initial gains in pain relief and physical function when rechecked at 1 year, a new study showed. Furthermore, patients who were in the sham treatment group and were later offered IDB achieved the same positive results as patients in the original treatment arm, researchers reported in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine.
Success rates soared to 75% for patients who waited less than 2 years for a spinal cord stimulator (SCS) implant, compared with 15% for patients whose implants happened 20 years after the onset of pain, according to a retrospective analysis. The length of time patients waited for a referral also varied by specialty, as shown in a scientific poster presented today at the 30th Annual Meeting of the American Academy of Pain Medicine.
Researchers found initial confirmation that a novel scaffold protein previously unassociated with the mu opioid receptor (MOR) regulates MOR-induced signaling activation. The MOR is the target of opioid drugs like morphine and is an important mechanism for pain regulation in the body. The research approach was designed to open new avenues to the treatment of chronic pain, a serious public health problem with major economic and societal costs.
American Academy of Pain Medicine physician leaders hail long-awaited labeling changes by FDA as a way to enhance patient safety in answer to a 2012 Citizen's Petition.
New President of American Academy of Pain Medicine Announces focus for upcoming year.
Few studies document short- and long-term pain and behavioral health in combat-injured service members with major limb trauma. In a 2-year longitudinal study, multiple post-injury pain and related outcomes are reported.
To evaluate the feasibility and efficacy of percutaneous microwave ablation (MWA) under CT guidance in the management of refractory pain in bone and soft tissue tumors. Researchers Concluded: When other therapies provide insufficient pain relief, percutaneous MWA treatment appears to be a feasible and effective technique for the management of refractory pain in bone and soft-tissue tumors. Ablation time appears to be highly reduced compared to radiofrequency ablation.
Dexmedetomidine is a highly selective α2 adrenergic agonist that has been shown to decrease the intensity of opioid-induced hyperalgesia (OIH). We aimed to investigate the anti hyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Conclusions: High-dose remifentanil induced hyperalgesia but, dexmedetomidine efficiently alleviated those symptoms. Dexmedetomidine may be a novel and effective treatment option for OIH.
Autologous bio-cellular grafts are increasingly encountered in surgical literature as a means to enhance tissue repair. Biologic graft use has expanded beyond simple platelet rich plasma to encompass bone marrow aspirate concentrate (BMAC) and adipose derived autologous stem cell products. The clinical application of such grafts in the treatment of low back pain is intriguing, but remains unproven.
Success of clinical trials is dependent on recruitment and maintenance of adequate numbers of study subjects. For pain trials, often characterized by low recruitment rates and high attrition, arriving at a desired cohort of subjects presents a challenge for most investigators. Web based recruiting is an alternative - expanding the research site’s reach to more potential subjects and allowing for prescreening before the first research visit. We describe development of this recruitment tool in a vulvodynia trial.
divergent effects of prescribed opioids in various domains among SCD patients, which likely modulate subsequent opioid taking behavior,” the authors wrote. “In all types of effects, biological effects appeared to be mediators of more indirect effects which led to alterations in subsequent opioid taking behavior.
Advanced Spinal Cord Stimulator Lead Anchoring And Multiple Lead Placement Technique Through An Individual Port: A Case Serie To introduce a novel and advanced lead anchoring technique as well as introduce the emerging technology of large single port introducers and percutaneous paddle leads.
All materials presented at the AAPM's 29th Annual Meeting are embargoed for news or other publication until the date and time of the presentation of the meeting unless AAPM grants permission for early publication in advance. EMBARGOED FOR RELEASE APRIL 11, 2013 5:30 PM Central Time/6:30 PM Eastern Time
Introduction: We evaluated radiofrequency (RF) heat lesion size for all cannula tip sizes, set temperatures, and lesion times typically used in interventional pain management. Collected data informs selection of cannulae and RF generator settings for RF treatments. Methods: Over 400 lesions were created in ex vivo animal tissue using tip diameters 23, 22, 20, 18, 16 gauge; tip lengths 5, 10, 15mm; set temperatures 60, 70, 80, 90°C; lesion times 1, 1.5, 2, 3, 5, 10 minutes. Average lesion size was assessed using computer-aided photographic temperature mapping of 5-20 lesions per configuration, and modeled using finite-element analysis. Results: Increasing cannula diameter from 22g to 16g increased average lateral lesion width by 65-69% (3-4mm) at 80°C and 2 minutes. Increasing set temperature from 60°C to 90°C increased lesion width 100-150% at 2 minutes; for example, width increased from 4.2mm to 10.4mm for the average 16g/10mm tip cannula. While lesions grew most rapidly over the firs
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right